New research shows that not only does psoriasis affect the quality of life of people living with the disease, it also affects those they are closest with. Psoriasis markedly worsens the global well-being of patients and their cohabitants, who experienced an impairment of their quality of life and higher levels of anxiety and depression, according to a new study in the Journal of the American Academy of Dermatology.
The researchers evaluated the influence of psoriasis on the levels of anxiety, depression and quality of life of the cohabitants of psoriatic patients with a study that included patients, cohabitants and controls, a total of 130 participants. Quality of life was measured with the Dermatology Life Quality Index (DLQI) and Family Dermatology Life Quality Index (FDLQI), and their psychological state with the Hospital Anxiety and Depression Scale. Demographic data of participants and clinical characteristics of patients were also gathered.
The presence of psoriasis impaired the quality of life of 87.8% of the cohabitants. FDLQI scores of cohabitants were significantly associated with the DLQI scores of the patients (rs = 0.554; P<.001). Anxiety and depression levels did not differ between patients and cohabitants, but were significantly higher than in the controls (P<.001).
The investigators noted that additional studies with larger numbers of patients and cohabitants are required to analyze differences between groups according to psoriasis severity.
Martínez-García E, Arias-Santiago S, Valenzuela-Salas I, et al. Quality of life in persons living with psoriasis patients. J Am Acad Dermatol. Published online ahead of print May 14, 2014.
New research shows that not only does psoriasis affect the quality of life of people living with the disease, it also affects those they are closest with. Psoriasis markedly worsens the global well-being of patients and their cohabitants, who experienced an impairment of their quality of life and higher levels of anxiety and depression, according to a new study in the Journal of the American Academy of Dermatology.
The researchers evaluated the influence of psoriasis on the levels of anxiety, depression and quality of life of the cohabitants of psoriatic patients with a study that included patients, cohabitants and controls, a total of 130 participants. Quality of life was measured with the Dermatology Life Quality Index (DLQI) and Family Dermatology Life Quality Index (FDLQI), and their psychological state with the Hospital Anxiety and Depression Scale. Demographic data of participants and clinical characteristics of patients were also gathered.
The presence of psoriasis impaired the quality of life of 87.8% of the cohabitants. FDLQI scores of cohabitants were significantly associated with the DLQI scores of the patients (rs = 0.554; P<.001). Anxiety and depression levels did not differ between patients and cohabitants, but were significantly higher than in the controls (P<.001).
The investigators noted that additional studies with larger numbers of patients and cohabitants are required to analyze differences between groups according to psoriasis severity.
Martínez-García E, Arias-Santiago S, Valenzuela-Salas I, et al. Quality of life in persons living with psoriasis patients. J Am Acad Dermatol. Published online ahead of print May 14, 2014.
New research shows that not only does psoriasis affect the quality of life of people living with the disease, it also affects those they are closest with. Psoriasis markedly worsens the global well-being of patients and their cohabitants, who experienced an impairment of their quality of life and higher levels of anxiety and depression, according to a new study in the Journal of the American Academy of Dermatology.
The researchers evaluated the influence of psoriasis on the levels of anxiety, depression and quality of life of the cohabitants of psoriatic patients with a study that included patients, cohabitants and controls, a total of 130 participants. Quality of life was measured with the Dermatology Life Quality Index (DLQI) and Family Dermatology Life Quality Index (FDLQI), and their psychological state with the Hospital Anxiety and Depression Scale. Demographic data of participants and clinical characteristics of patients were also gathered.
The presence of psoriasis impaired the quality of life of 87.8% of the cohabitants. FDLQI scores of cohabitants were significantly associated with the DLQI scores of the patients (rs = 0.554; P<.001). Anxiety and depression levels did not differ between patients and cohabitants, but were significantly higher than in the controls (P<.001).
The investigators noted that additional studies with larger numbers of patients and cohabitants are required to analyze differences between groups according to psoriasis severity.
Martínez-García E, Arias-Santiago S, Valenzuela-Salas I, et al. Quality of life in persons living with psoriasis patients. J Am Acad Dermatol. Published online ahead of print May 14, 2014.
.jpg)
.jpg)
New research shows that not only does psoriasis affect the quality of life of people living with the disease, it also affects those they are closest with. Psoriasis markedly worsens the global well-being of patients and their cohabitants, who experienced an impairment of their quality of life and higher levels of anxiety and depression, according to a new study in the Journal of the American Academy of Dermatology.
